Breitling Lutz Philipp, Dahmen Norbert, Illig Thomas, Rujescu Dan, Nitz Barbara, Raum Elke, Winterer Georg, Rothenbacher Dietrich, Brenner Hermann
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Pharmacogenet Genomics. 2009 Aug;19(8):657-9. doi: 10.1097/FPC.0b013e32832fabf3.
Genome-wide studies have identified single nucleotide polymorphisms associated with smoking behaviour and nicotine dependence. Less is known about genetic determinants of smoking cessation, but rs4680 in COMT has recently been shown to explain a substantial proportion of the variation in cessation in the general population. We attempted to replicate the reported, clinically relevant effect in a population-based retrospective cohort analysis of 1443 ever-heavy smokers, of whom 925 had reached abstinence. In Cox regression models, neither rs4680 nor two polymorphisms nearby were associated with smoking cessation. The adjusted relative cessation rate (95% confidence interval) in rs4680 methionine carriers in reference to valine homozygotes was 0.97 (0.83-1.12). The absence of a significant effect of rs4680 in this statistically well-powered study - the 95% confidence interval even excluding the previously reported effect - highlights the need for rigorous replication efforts and suggests that rs4680 genotype should not yet be considered informative for smoking patient care.
全基因组研究已经确定了与吸烟行为和尼古丁依赖相关的单核苷酸多态性。关于戒烟的遗传决定因素知之甚少,但最近有研究表明,儿茶酚-O-甲基转移酶(COMT)基因中的rs4680能够解释普通人群中戒烟差异的很大一部分。我们试图在一项基于人群的回顾性队列分析中重复上述已报道的、具有临床相关性的效应,该分析纳入了1443名曾经重度吸烟的人群,其中925人已成功戒烟。在Cox回归模型中,rs4680及其附近的两个多态性均与戒烟无关。与缬氨酸纯合子相比,rs4680蛋氨酸携带者的校正相对戒烟率(95%置信区间)为0.97(0.83 - 1.12)。在这项统计学效力充足的研究中,rs4680未显示出显著效应——95%置信区间甚至不包括先前报道的效应——这凸显了进行严格重复研究的必要性,并表明rs4680基因型目前不应被视为对吸烟患者护理具有参考价值。